• British Journal of Dermatology
    Interleukin-17A derived from mast cells: evidence for an autoinflammatory loop in hidradenitis suppurativa?
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis
    18 October 2023
  • Journal of Investigative Dermatology
    Immune Classification of Hidradenitis Suppurativa: Modulation by Secukinumab
    Επίσημα το άρθρο εδώ
    Dimitra Stergianou, Styliani Micha, Vassiliki Tzanetakou, Theodora Kanni, Theologia Gkavogianni, Alexandros Katoulis, Evangelos J. Giamarellos-Bourboulis
    May 19, 2023
  • British Journal of Dermatology
    Keratinocytes as drivers of hidradenitis suppurativa inflammation: need for priming
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis
    17 January 2023
  • Dermatology Impact of Single Nucleotide Polymorphisms of the Promoter of the TNF Gene on Adalimumab Treatment Responses in Hidradenitis Suppurativa
    Επίσημα το άρθρο εδώ
    Argyropoulou M, Trigoni A, Kaffenberger J, Stergianou D, Damoraki G, Mingiani E, Micha S, Krispinsky A, Meltzanidou P, Kanni T, Lazaridou E, Giamarellos-Bourboulis EJ.
    16 June 2023
  • British Journal of Dermatology
    Modulation of keratin deposition and pathogenesis of hidradenitis suppurativa: evidence coming from pachyonychia congenita
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis
    01 November 2022
  • British Journal of Dermatology
    Neutrophil trafficking: the missing link in the pathogenesis of hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis
    01 July 2021
  • Dermatology
    Staphylococcus aureus Carriage in Hidradenitis Suppurativa: Impact on Response to Adalimumab
    Επίσημα το άρθρο εδώ
    Stergianou D, Tzanetakou V, Argyropoulou M, Kanni T, Bagos PG, Giamarellos-Bourboulis EJ.
    5 January 2021
  • Clinical and Experimental Dermatology
    MABp1 targeting interleukin‐1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open‐label extension period
    Επίσημα το άρθρο εδώ Kanni T, Argyropoulou M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ.
    01 January 2021
  • Expert Opinion on Drug Safety
    Long-term safety of adalimumab for patients with moderate-to-severe hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Tzanetakou V, Stergianou D, Giamarellos-Bourboulis EJ.
    28 February 2020
  • British Journal of Dermatology
    Staphylococcus aureus and host interaction in the flare‐ups of hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis
    01 November 2019
  • British Journal of Dermatology
    Cost‐savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real‐world cohort
    Επίσημα το άρθρο εδώ
    Argyropoulou M, Kanni T, Kyprianou M, Melachroinopoulos N, Giamarellos-Bourboulis EJ.
    01 May 2019
  • British Journal of Dermatology
    Impact of Toll‐like receptor‐4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Savva A, Kanni T, Damoraki G, Kotsaki A, Giatrakou S, Grech I, Katoulis A, Papadavid E, Giamarellos-Bourboulis EJ.
    01 February 2013
  • British Journal of Dermatology
    Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Kelekis NL, Efstathopoulos E, Balanika A, Spyridopoulos TN, Pelekanou A, Kanni T, Savva A, Brountzos E, Giamarellos-Bourboulis EJ.
    01 June 2010
  • Experimental Dermatology
    Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial
    Επίσημα το άρθρο εδώ
    Pelekanou A, Kanni T, Savva A, Mouktaroudi M, Raftogiannis M, Kotsaki A, Giamarellos-Bourboulis EJ.
    20 May 2010
  • British Journal of Dermatology
    An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Giamarellos-Bourboulis EJ, Pelekanou E, Antonopoulou A, Petropoulou H, Baziaka F, Karagianni V, Stavrianeas N, Giamarellou H.
    01 March 2008
  • British Journal of Dermatology
    Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C, Mouktaroudi M, Spyridaki E, Baziaka F, Pelekanou A, Giamarellou H, Stavrianeas NG.
    01 January 2007
  • JAMA Dermatology
    Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice. A HiSTORIC Consensus Statement
    Επίσημα το άρθρο εδώ
    September 27, 2023
  • British Journal of Dermatology
    Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project
    Επίσημα το άρθρο εδώ
    Amit Garg, Sahil Rawal, Oleg Akilov, Afsaneh Alavi, Christine Ardon, Falk G Bechara, Arnon D Cohen, Steven R Cohen, Steven Daveluy, Véronique del Marmol, Maïa Delage, Solveig Esmann, Shani Fisher, Evangelos J Giamarellos-Bourboulis, Amelia Glowaczewska, Noah Goldfarb, Elena Gonzalez Brant, Øystein Grimstad, Sandra Guilbault, Iltefat Hamzavi, Rosalind Hughes, John R Ingram, Gregor B E Jemec, Qiang Ju, Naomi Kappe, Brian Kirby, Joslyn S Kirby, Michelle A Lowes, Lukasz Matusiak, Stella Micha, Robert G Micheletti, Angela P Miller, Dagfinn Moseng, Haley B Naik, Aude Nassif, Georgios Nikolakis, So Yeon Paek, Jose Carlos Pascual, Errol Prens, Barry Resnik, Hassan Riad, Christopher Sayed, Saxon D Smith, Yssra Soliman, Jacek C Szepietowski, Jerry Tan, Linnea Thorlacius, Thrasyvoulos Tzellos, Hessel H van der Zee, Bente Villumsen, Lanqi Wang, Christos C Zouboulis, Andrew Strunk
    09 March 2023
  • International Journal of Molecular Sciences
    Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1—A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious Diseases.
    Επίσημα το άρθρο εδώ
    23 May 2023
  • The Lancet
    Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
    Επίσημα το άρθρο εδώ
    February 03, 2023
  • Dermatology
    External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort
    Επίσημα το άρθρο εδώ
    van Straalen KR, Tzellos T, Alavi A, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Guillem P, Gulliver W, Jemec GBE, Katoulis A, Koenig A, Lazaridou E, Lowes MA, Marzano AV, Matusiak L, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Prens EP, Romaní J, Saunte DM, Sayed C, Skroza N, Stergianou D, Szepietowski JC, Trigoni A, Vilarrasa E, Kyrgidis A, Zouboulis CC, van der Zee HH.
    13 June 2023
  • British Journal of Dermatology
    Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project
    Επίσημα το άρθρο εδώ
    Midgette B, Strunk A, Akilov O, Alavi A, Ardon C, Bechara FG, Cohen AD, Cohen S, Daveluy S, Del Marmol V, Delage M, Esmann S, Fisher S, Giamarellos-Bourboulis EJ, Glowaczewska A, Goldfarb N, Brant EG, Grimstad Ø, Guilbault S, Hamzavi I, Hughes R, Ingram JR, Jemec GBE, Ju Q, Kappe N, Kirby B, Kirby JS, Lowes MA, Matusiak L, Micha S, Micheletti R, Miller AP, Moseng D, Naik H, Nassif A, Nikolakis G, Paek SY, Pascual JC, Prens E, Resnik B, Riad H, Sayed C, Smith SD, Soliman Y, Szepietowski JC, Tan J, Thorlacius L, Tzellos T, van der Zee HH, Villumsen B, Wang L, Zouboulis C, Garg A.
    01 December 2022
  • British Journal of Dermatology
    Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study
    Επίσημα το άρθρο εδώ
    Di Cesare A, Nikolakis G, Kanni T, Giamarellos-Bourboulis EJ, Matusiak L, Szepietowski JC, Zouboulis CC, Prignano F.
    01 September 2022
  • JAMA Surgery
    Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial
    Επίσημα το άρθρο εδώ
    Bechara FG, Podda M, Prens EP, Horváth B, Giamarellos-Bourboulis EJ, Alavi A, Szepietowski JC, Kirby J, Geng Z, Jean C, Jemec GBE, Zouboulis CC.
    August 18, 2021
  • Journal of the American Academy of Dermatology
    The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
    Επίσημα το άρθρο εδώ
    van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH.
    January 20, 2021
  • Experimental Dermatology
    Anti-COVID-19 measurements for hidradenitis suppurativa patients.
    Επίσημα το άρθρο εδώ
    Giamarellos-Bourboulis EJ, Bettoli V, Jemec GBE, Del Marmol V, Marzano AV, Prens EP, Tzellos T, Zouboulis CC.
    04 June 2021
  • Experimental Dermatology
    Target molecules for future hidradenitis suppurativa treatment
    Επίσημα το άρθρο εδώ
    Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, Nikolakis G, Sayed CJ, Tzellos T, Wolk K, Prens EP.
    04 June 2021
  • Experimental Dermatology
    What causes hidradenitis suppurativa ?—15 years after
    Επίσημα το άρθρο εδώ
    Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH.
    14 October 2020
  • Journal of the European Academy of Dermatology & Venereology
    Further evidence for the immediate knowledge improvement through EADV Schools on hidradenitis suppurativa/acne inversa
    Επίσημα το άρθρο εδώ
    Zouboulis CC, Del Marmol V, Jemec GBE, Katoulis AC, Prens E, Giamarellos-Bourboulis EJ.
    13 June 2020
  • Experimental Dermatology
    Endpoints of clinical trials for Hidradenitis Suppurativa: Proceedings of a round-table session
    Επίσημα το άρθρο εδώ
    Zouboulis CC, Gulliver W, Ingram J, Kirby B, Giamarellos-Bourboulis EJ, Podda M, Tzellos T, Jemec GBE.
    21 July 2020
  • British Journal of Dermatology
    Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab
    Επίσημα το άρθρο εδώ
    Giamarellos-Bourboulis EJ, Argyropoulou M, Kanni T, Spyridopoulos T, Otto I, Zenker O, Guo R, Riedemann NC.
    01 July 2020
  • Journal of the European Academy of Dermatology
    Evaluating patients’ unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
    Επίσημα το άρθρο εδώ
    Garg A, Neuren E, Cha D, Kirby JS, Ingram JR, Jemec GBE, Esmann S, Thorlacius L, Villumsen B, Marmol VD, Nassif A, Delage M, Tzellos T, Moseng D, Grimstad Ø, Naik H, Micheletti R, Guilbault S, Miller AP, Hamzavi I, van der Zee H, Prens E, Kappe N, Ardon C, Kirby B, Hughes R, Zouboulis CC, Nikolakis G, Bechara FG, Matusiak L, Szepietowski J, Glowaczewska A, Smith SD, Goldfarb N, Daveluy S, Avgoustou C, Giamarellos-Bourboulis E, Cohen S, Soliman Y, Brant EG, Akilov O, Sayed C, Tan J, Alavi A, Lowes MA, Pascual JC, Riad H, Fisher S, Cohen A, Paek SY, Resnik B, Ju Q, Wang L, Strunk A.
    July 03, 2019
  • Journal of Investigative Dermatology
    The IL-1 Pathway Is Hyperactive in Hidradenitis Suppurativa and Contributes to Skin Infiltration and Destruction
    Επίσημα το άρθρο εδώ
    Witte-Händel E, Wolk K, Tsaousi A, Irmer ML, Mößner R, Shomroni O, Lingner T, Witte K, Kunkel D, Salinas G, Jodl S, Schmidt N, Sterry W, Volk HD, Giamarellos-Bourboulis EJ, Pokrywka A, Döcke WD, Schneider-Burrus S, Sabat R.
    December 05, 2018
  • British Journal of Dermatology
    Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?
    Επίσημα το άρθρο εδώ
    Kanni T, Zenker O, Habel M, Riedemann N, Giamarellos-Bourboulis EJ.
    01 August 2018
  • Journal of Investigative Dermatology
    MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study
    Επίσημα το άρθρο εδώ
    Kanni T, Argyropoulou M, Spyridopoulos T, Pistiki A, Stecher M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ.
    November 09, 2017
  • Wounds
    Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies.
    Επίσημα το άρθρο εδώ
    Evangelos J Giamarellos-Bourboulis, Jeffrey Sobell, Caitriona Ryan, Pierre J Wolkenstein, Ziqian Geng, Gerit D Mulder
    November 2017
  • British Journal of Dermatology
    Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity
    Επίσημα το άρθρο εδώ
    Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R
    01 November 2017
  • The New England Journal of Medicine
    Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa Επίσημα το άρθρο εδώ
    Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB.
    August 4, 2016
  • Journal of Investigative Dermatology
    High Copy Numbers of β-Defensin Cluster on 8p23.1, Confer Genetic Susceptibility, and Modulate the Physical Course of Hidradenitis Suppurativa/Acne Inversa
    Επίσημα το άρθρο εδώ
    Giamarellos-Bourboulis EJ, Platzer M, Karagiannidis I, Kanni T, Nikolakis G, Ulrich J, Bellutti M, Gollnick H, Bauer M, Zouboulis CC, Huse K.
    May 07, 2016
  • JAMA Dermatology
    Safety and Efficacy of Anakinra in Severe Hidradenitis SuppurativaA Randomized Clinical Trial
    Επίσημα το άρθρο εδώ
    Tzanetakou V, Kanni T, Giatrakou S, Katoulis A, Papadavid E, Netea MG, Dinarello CA, van der Meer JWM, Rigopoulos D, Giamarellos-Bourboulis EJ.
    January 2016
  • PLoS One
    Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
    Επίσημα το άρθρο εδώ
    Kanni T, Tzanetakou V, Savva A, Kersten B, Pistiki A, van de Veerdonk FL, Netea MG, van der Meer JW, Giamarellos-Bourboulis EJ.
    June 19, 2015
  • Cytokine
    Haplotypes of IL-12Rβ1 impact on the clinical phenotype of hidradenitis suppurativa
    Επίσημα το άρθρο εδώ
    Giatrakos S, Huse K, Kanni T, Tzanetakou V, Kramer M, Grech I, Papadavid E, Katoulis A, Stavrianeas N, Nothnagel M, Platzer M, Bauer M, Giamarellos-Bourboulis EJ.
    May 2013
  • Experimental Dermatology
    What causes hidradenitis suppurativa?
    Επίσημα το άρθρο εδώ
    Kurzen H, Kurokawa I, Jemec GB, Emtestam L, Sellheyer K, Giamarellos-Bourboulis EJ, Nagy I, Bechara FG, Sartorius K, Lapins J, Krahl D, Altmeyer P, Revuz J, Zouboulis CC.
    01 May 2009